Trials / Not Yet Recruiting
Not Yet RecruitingNCT06193317
Effects of taVNS on Fibromyalgia Pain
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 152 (estimated)
- Sponsor
- Spaulding Rehabilitation Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Transauricular vagus nerve stimulation (taVNS) is a newer delivery system, using a non-invasive stimulation device placed at the ear's concha. TaVNS is a portable, safe, and low-cost intervention, and according to some studies, taVNS may influence nociception and pain perception, which can lead to potential applications for various painful illnesses, including fibromyalgia (FM). This trial aims to investigate the clinical effects of taVNS on pain control in FM subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transauricular vagus nerve stimulation (taVNS) | Transauricular vagus nerve stimulation (taVNS) is a simple technique in which small surface electrodes are placed over the skin of the ear that are thought to be innervated by the auricular branch of the vagus nerve (ABVN). |
Timeline
- Start date
- 2026-06-01
- Primary completion
- 2028-05-01
- Completion
- 2029-05-01
- First posted
- 2024-01-05
- Last updated
- 2025-09-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06193317. Inclusion in this directory is not an endorsement.